INNOVATE (VATE) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on June 11, 2026, with voting available online, by phone, or by mail.

• Key business highlights include refinancing transactions, revenue growth in DBM Global, regulatory milestones in Pansend Life Sciences, and expansion in Broadcasting.

• The company emphasizes active stockholder engagement and transparency, with ongoing dialogue on executive compensation, governance, and ESG matters.

Voting matters and shareholder proposals

• Four proposals will be voted on: election of four directors, advisory say-on-pay vote, amendment to increase shares in the equity award plan, and ratification of BDO USA, P.C. as auditor.

• The Board recommends voting FOR all proposals and nominees.

• Only stockholders of record as of April 22, 2026, are entitled to vote.

Board of directors and corporate governance

• The Board consists of four independent directors, all nominated for re-election, with diverse backgrounds in business, finance, and public policy.

• Three standing committees: Audit, Compensation, and Nominating & Governance, all composed of independent directors.

• The company separates the roles of Chairman and CEO and encourages director education and stockholder communications.

• Corporate governance guidelines address director qualifications, independence, and succession planning.